What is a stock summary page? Click here for an overview.
Business Description
Apogee Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US03770N1019
Description
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.01 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | -24.64 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.31 | |||||
| 9-Day RSI | 37.29 | |||||
| 14-Day RSI | 41.67 | |||||
| 3-1 Month Momentum % | -34.29 | |||||
| 6-1 Month Momentum % | -44.78 | |||||
| 12-1 Month Momentum % | -47.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 18.55 | |||||
| Quick Ratio | 18.55 | |||||
| Cash Ratio | 18.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -24.37 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -25.57 | |||||
| ROA % | -25.61 | |||||
| ROIC % | -175.96 | |||||
| ROC (Joel Greenblatt) % | -2926.56 | |||||
| ROCE % | -31.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.69 | |||||
| Price-to-Tangible-Book | 2.69 | |||||
| EV-to-EBIT | -7.04 | |||||
| EV-to-EBITDA | -7.05 | |||||
| EV-to-FCF | -9.8 | |||||
| Price-to-Net-Current-Asset-Value | 3.92 | |||||
| Price-to-Net-Cash | 3.99 | |||||
| Earnings Yield (Greenblatt) % | -14.2 | |||||
| FCF Yield % | -9.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APGE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apogee Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.29 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 55.66 | ||
| 14-Day RSI | 41.67 | ||
| 14-Day ATR ($) | 2.65016 | ||
| 20-Day SMA ($) | 38.8085 | ||
| 12-1 Month Momentum % | -47.68 | ||
| 52-Week Range ($) | 29.1 - 63.5 | ||
| Shares Outstanding (Mil) | 58.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apogee Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apogee Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Apogee Therapeutics Inc Frequently Asked Questions
What is Apogee Therapeutics Inc(APGE)'s stock price today?
The current price of APGE is $32.45. The 52 week high of APGE is $63.50 and 52 week low is $29.10.
When is next earnings date of Apogee Therapeutics Inc(APGE)?
The next earnings date of Apogee Therapeutics Inc(APGE) is 2025-05-13 Est..
Does Apogee Therapeutics Inc(APGE) pay dividends? If so, how much?
Apogee Therapeutics Inc(APGE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers